constipation

Celiac disease is a chronic autoimmune disease caused by consumption of gluten in people with specific genetic markers. Celiac disease affects about 1% of people worldwide and people can start having symptoms at any age. Individuals at increased risk include those with a first-degree relative who has celiac disease and those with autoimmune diseases (eg, type 1 diabetes or Hashimoto thyroiditis) and certain chromosomal conditions (Down syndrome, Turner syndrome, or Williams syndrome).

Author/s:

Kristin L. Walter

My Constipation Action Plan

Rowan Hutchins — Sun, 19 Mar 2023 05:00:00 +0000

Date Added:

March 19, 2023

Publisher:

Uniformed Services University

Publication Date:

January 17, 2023

URL:

My Constipation Action Plan

Type:

Patient Education Materials

Keywords

MeSH

An action plan for parents of children with chronic functional constipation developed by the Uniformed Services University. James W. Mold, MD, MPH

Free full text

An action plan for parents of children with chronic functional constipation developed by the Uniformed Services University.

Chronic Constipation

John Bayhi — Sat, 02 Nov 2019 16:29:30 +0000

Date Added:

November 2, 2019

Journal/Publication:

Mayo Clinic Proceedings

Publisher:

Mayo Foundation for Medical Education and Research

Publication Date:

November 1, 2019

Issue:

Volume:

Pages:

2340-2357

URL:

Chronic Constipation

Type:

Meta-analyses, Reviews, and Guidelines

Format:

Article

DOI (1):

10.1016/j.mayocp.2019.01.031

Keywords

chronic constipation

constipation

laxatives

opiod-induced consitpation

MeSH

Humans

laxatives

constipation

physicians, primary care

Biofeedback, Psychology

Opiate Alkaloids

This is a comprehensive review of the causes, evaluation, and treatment of chronic constipation. James W. Mold, MD, MPH

Commercial full text (fees may apply)

View

Constipation is a common symptom that may be primary (idiopathic or functional) or associated with a number of disorders or medications. Although most constipation is self-managed by patients, 22% seek health care, mostly to primary care physicians (>50%) and gastroenterologists (14%), resulting in large expenditures for diagnostic testing and treatments. There is strong evidence that stimulant and osmotic laxatives, intestinal secretagogues, and peripherally restricted μ-opiate antagonists are effective and safe; the lattermost drugs are a major advance for managing opioid-induced constipation. Constipation that is refractory to available laxatives should be evaluated for defecatory disorders and slow-transit constipation using studies of anorectal function and colonic transit. Defecatory disorders are often responsive to biofeedback therapies, whereas slow-transit constipation may require surgical intervention in selected patients. Both efficacy and cost should guide the choice of treatment for functional constipation and opiate-induced constipation. Currently, no studies have compared inexpensive laxatives with newer drugs that work by other mechanisms.

Author/s:

Bharucha, AE, Wald, A

Chronic Constipation

Tracy Ashby — Mon, 13 May 2019 05:00:00 +0000

Date Added:

May 13, 2019

Journal/Publication:

Mayo Clinic Proceedings

Publisher:

Elsevier Inc.

Publication Date:

April 28, 2019

URL:

Chronic Constipation

Type:

Meta-analyses, Reviews, and Guidelines

CME Credits:

Format:

Article

DOI (1):

10.1016/j.mayocp.2019.01.031

Keywords

chronic constipation

primary care

PMID (1):

31054770

MeSH

constipation

colonic diseases

physicians, primary care

laxatives

gastroenterologists

This is a comprehensive review of the diagnosis and management of chronic constipation from the Mayo Clinic. One hour of Category 1 CME credit is available for reading it and taking the online test. James W. Mold, MD, MPH

Commercial full text (fees may apply)

View

Author/s:

Bharucha, Adil E., Wald, Arnold